wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37788217-C117455B-117B-47E1-B1E3-0793CEEA334C
Q37788217-C117455B-117B-47E1-B1E3-0793CEEA334C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37788217-C117455B-117B-47E1-B1E3-0793CEEA334C
Investigational agents for Crohn's disease.
P2860
Q37788217-C117455B-117B-47E1-B1E3-0793CEEA334C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37788217-C117455B-117B-47E1-B1E3-0793CEEA334C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4be0ea231523b7ffff679d324e3c7c97b8227bda
P2860
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease